These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 23434453

  • 1. Value of ¹⁸F-FDG PET/CT in the diagnosis of primary gastric cancer via stomach distension.
    Ma Q, Xin J, Zhao Z, Guo Q, Yu S, Xu W, Liu C, Zhai W.
    Eur J Radiol; 2013 Jun; 82(6):e302-6. PubMed ID: 23434453
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
    Yun M, Lim JS, Noh SH, Hyung WJ, Cheong JH, Bong JK, Cho A, Lee JD.
    J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706
    [Abstract] [Full Text] [Related]

  • 4. Incremental diagnostic utility of gastric distension FDG PET/CT.
    Le Roux PY, Duong CP, Cabalag CS, Parameswaran BK, Callahan J, Hicks RJ.
    Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):644-53. PubMed ID: 26487512
    [Abstract] [Full Text] [Related]

  • 5. 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.
    Zhou M, Wang C, Hu S, Zhang Y, Yao Z, Li J, Guo W, Zhang Y.
    Nucl Med Commun; 2013 Jul; 34(7):694-700. PubMed ID: 23604223
    [Abstract] [Full Text] [Related]

  • 6. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD, Carlson ER, Heidel RE.
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [Abstract] [Full Text] [Related]

  • 7. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
    Lee DY, Lee CH, Seo MJ, Lee SH, Ryu JS, Lee JJ.
    Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
    [Abstract] [Full Text] [Related]

  • 8. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.
    Yun M, Choi HS, Yoo E, Bong JK, Ryu YH, Lee JD.
    J Nucl Med; 2005 Jun; 46(6):953-7. PubMed ID: 15937305
    [Abstract] [Full Text] [Related]

  • 9. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited.
    Zhang X, Wu F, Han P.
    Hell J Nucl Med; 2014 Jun; 17(3):177-83. PubMed ID: 25526754
    [Abstract] [Full Text] [Related]

  • 10. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
    Zhang M, Jiang X, Zhang M, Xu H, Zhai G, Li B.
    J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR, Chung SK, Park HL, Choi WH, Kim YK, Lee KY, Wang YP.
    Biomed Mater Eng; 2014 Apr; 24(6):3091-103. PubMed ID: 25227018
    [Abstract] [Full Text] [Related]

  • 12. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
    Guan ZW, Xu BX, Wang RM, Sun L, Tian JH.
    Hell J Nucl Med; 2013 Apr; 16(2):97-102. PubMed ID: 23687644
    [Abstract] [Full Text] [Related]

  • 13. Regional PET/CT after water gastric inflation for evaluating loco-regional disease of gastric cancer.
    Lee SJ, Lee WW, Yoon HJ, Lee HY, Lee KH, Kim YH, Park DJ, Kim HH, So Y, Kim SE.
    Eur J Radiol; 2013 Jun; 82(6):935-42. PubMed ID: 23410909
    [Abstract] [Full Text] [Related]

  • 14. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
    Han A, Xue J, Hu M, Zheng J, Wang X.
    Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effect of positive and negative oral contrast agents on (18)F-FDG PET/CT scan.
    Sun XG, Huang G, Liu JJ, Wan LR.
    Hell J Nucl Med; 2009 Oct; 12(2):115-8. PubMed ID: 19675862
    [Abstract] [Full Text] [Related]

  • 16. [Diagnostic value of (18)F-FDG PET/CT imaging plus serum tumor marker assays for pulmonary lesions and clinical significance of SUVmax].
    Zhang TM, Zhang LM, Liu Y, Zhang ZF, Wang CL.
    Zhonghua Yi Xue Za Zhi; 2012 Nov 06; 92(41):2901-4. PubMed ID: 23328236
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S, Mittal BR, Bhasin D, Srinivasan R, Rana S, Das A, Nada R, Bhattacharya A, Gupta R, Kapoor R.
    J Gastroenterol Hepatol; 2013 Feb 06; 28(2):255-61. PubMed ID: 23278193
    [Abstract] [Full Text] [Related]

  • 20. Accuracy of 18F-FDG PET/CT, Multidetector CT, and MR Imaging in the Diagnosis of Pancreatic Cysts: A Prospective Single-Center Study.
    Kauhanen S, Rinta-Kiikka I, Kemppainen J, Grönroos J, Kajander S, Seppänen M, Alanen K, Gullichsen R, Nuutila P, Ovaska J.
    J Nucl Med; 2015 Aug 06; 56(8):1163-8. PubMed ID: 26045314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.